Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies
Objective: Chagas disease constitutes a major public health problem in Latin America. Correctly designed pharmacokinetic, safety, and bioequivalence studies are desirable in order to fill the knowledge gaps that presently exist on available drugs. It is necessary to develop accurate, simple, reprodu...
Guardado en:
| Autores principales: | Marson, María Elena, Dana, Diego Dante, Altcheh, Jaime Marcelo, García Bournissen, Facundo, Mastrantonio Garrido, Guido Enrique |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/99862 https://ri.conicet.gov.ar/11336/25466 |
| Aporte de: |
Ejemplares similares
-
Presence of benznidazole conjugated metabolites in urine identified by β-glucuronidase treatment
por: Marson, María Elena, et al.
Publicado: (2020) -
A Simple and Efficient HPLC Method for Benznidazole Dosage in Human Breast Milk
por: Marson, María Elena, et al.
Publicado: (2013) -
Pediatric Clinical Pharmacology Studies in Chagas Disease
por: Garcia Bournissen, Facundo, et al.
Publicado: (2009) -
Population pharmacokinetic study of benznidazole in pediatric chagas disease suggests efficacy despite lower plasma concentrations than in adults
por: Altcheh, J., et al.
Publicado: (2014) -
Identification of N-benzylacetamide as a major component of human plasmatic metabolic profiling of benznidazole
por: Marson, María Elena, et al.
Publicado: (2015)